Violation Tracker Individual Record
Date:January 28, 2010
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Following an earlier guilty verdict GlaxoSmithKline was ordered to pay $5.8 million in civil penalties for deceptive marketing of several of its drugs. The company later reached a settlement for $3.7 million.
Level of Government:state
Action Type:agency action
Agency:Kentucky Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:United Kingdom
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.